All In MedTech

Device Trial Radar · NCT02471638

DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass

PQ Bypass Systems for Femoropopliteal Bypass II (PQB 4 FP II)

Last checked: Nov 20, 2026Latest source record: Jun 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

78

Actual

Start

Jan 2015

Primary completion

Sep 2018

Study completion Jun 2020

Sponsor

Lead sponsor
EndologixNot on our public-company list
Sponsor type
Industry
First posted
Jun 15, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the safety and performance of the PQ Bypass System to access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.

Conditions

  • Peripheral Arterial Disease

Interventions

  • PQ Bypass System for Femoropopliteal BypassDevice

    To access, deliver guidewires and implant stent grafts for a percutaneous fem-pop bypass.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Lesions With Primary PatencyTime frame: 6 Months
  2. Number of Lesions With Any Major Adverse Event (MAE) at One Month Post-procedureTime frame: One Month

Locations

8 sites in 6 countries. Site status is shown where the registry gives one.

  • Universidad Católica de Chile

    Santiago, Chile

  • University of Leipzig Medical Centre

    Leipzig, Germany

  • Ospedale San Raffaele

    Milan, Italy

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.